Apr 1, 2009
By:Joanna Breitstein
From her start as a physician working in apartheid-era South Africa to the dramatic turnaround and takeover of Millennium, Deborah Dunsire has lived a life that has defied all expectations.
 |
A new equation to bridge health and wealth
Feb 1, 2009
By:Joanna Breitstein
The world is suffering. But just over the horizon is a new access equation that could speed innovative vaccines to where they're needed most.
|
As the company marches toward its patent cliff, CEO John Lechleiter has a bold new plan to save it. But it's going to take more than ImClone to restore Lilly to its former glory. Does Lechleiter have what it takes?
Nov 1, 2008
By:Joanna Breitstein
Some say it's just another pharma facing its patent cliff. But others say this company's got it worse. With new CEO John Lechleiter in charge, can Lilly find its way back from the edge?
|
Amgen's future lies in the hands of denosumab lead investigators Dr. Javier San Martin and Dr. Roger Dansey. Pharm Exec talked with them about the experience of developing what could be the industry's most promising new product
Oct 1, 2008
By:Joanna Breitstein
Amgen's salvation just may be denosumab. We sit down to talk with the head scientists driving the drug.
|
Sep 1, 2008
By:Joanna Breitstein
The industry is a-changing. Here are eight seminal events that describe how.
|
Jun 1, 2008
By:Walter Armstrong, Joanna Breitstein
In our first ever Emerging Leadership Awards, we profile 45 talented young professionals who will lead pharma into the next generation
|
Apr 1, 2008
By:Joanna Breitstein
Here's the saga of how market research, health outcomes, and dozens of other tools that connect the industry to patients came to be.
|
With industry-wide layoffs, how will pharma companies staff their sales organizations? Pharmaceutical executive and its sister publication, pharmaceutical representative, convened an executive roundtable to find out.
Mar 1, 2008
By:Joanna Breitstein, Matthew Herman
Industry insiders explain how pharma companies are reorganizing their salesforces in the wake of industry-wide layoffs
|
Doomsayers predict that the post-antibiotic age is coming. But rising rates of antimicrobial resistance show that in many parts of the world, it is already here.
Feb 1, 2008
By:Joanna Breitstein
US officials think they can control MRSA and other "superbugs," but dangerous bacteria know no boundaries. What does the world do when its drugs stop working?
|
| 
PharmExec Blog
Follow Us
RSS
Bookstore
What's the best managed pharma? Professor Bill Trombetta of Saint Joseph's University attempts to answer the question in Pharm Exec's Industry Audit.
Applying E-Commerce to Support Discovery and Development of Medicines: Key Lessons and Learnings Tuesday, December 15 @ 11:00 a.m. ET
The most respected annual ranking of top 50 pharmaceutical companies by prescription drug sales... Who's in, who's back, and who's out?